← SynDRA
SMI-4a
SynDRA canonical compound SYN1969915 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | AKR1B1 | PIM1 | PIM2 |
| Mechanism of action | Pim kinase inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- SMI 4a
- TCS PIM-1-4a
- (Z)-SMI-4a
- (Z)-5-(3-(trifluoromethyl)benzylidene)thiazolidine-2,4-dione
- (5Z)-5-[3-(trifluoromethyl)benzylidene]-1,3-thiazolidine-2,4-dione
- CHEMBL183906
- (5Z)-5-[[3-(TRIFLUOROMETHYL)PHENYL]METHYLENE]-2,4-THIAZOLIDINEDIONE
- (5Z)-5-[[3-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione
- C11H6F3NO2S
- (Z)-5-(3-(Trifluoromethyl)benzylidene)-thiazolidine-2,4-dione
- (5Z)-5-{[3-(trifluoromethyl)phenyl]methylidene}-1,3-thiazolidine-2,4-dione
- Pim inhibitor 4a
- 3vc4
- SMI-4q
- 5-(3-(Trifluoromethyl)benzylidene)thiazolidine-2,4-dione
- 5-[3-(Trifluoromethyl)benzylidene]thiazolidine-2,4-dione
- cc-717
- thiazolidine-2,4-dione, 4a
- SCHEMBL2541382
- SCHEMBL2541388
- BDBM26626
- AOB6260
- EX-A111
- SYN1113
- BDBM138364
- HMS3229J21
- 2720AH
- HY-16576A
- MFCD01152003
- s8005
- ZINC12576047
- AKOS001314163
- SMI-4a, >=98% (HPLC)
- CCG-265027
- NCGC00345836-02
- NCGC00345836-14
- AC-32861
- HY-15474
- AB0165836
- EC-000.2291
Look up SMI-4a in the interactive SynDRA portal →